0,872  0,004  Caspase 9 stimulant
0,853  0,004  Tubulin antagonist
0,839  0,005  Antineoplastic (lung cancer)
0,809  0,004  Caspase 3 stimulant
0,810  0,008  Antineoplastic (breast cancer)
0,807  0,016  Apoptosis agonist
0,784  0,005  Prostate cancer treatment
0,764  0,009  Antineoplastic (colorectal cancer)
0,754  0,009  Antineoplastic (colon cancer)
0,727  0,005  Antimitotic
0,723  0,005  Antineoplastic (non-small cell lung cancer)
0,716  0,009  Antihypercholesterolemic
0,710  0,005  Antineoplastic (carcinoma)
0,702  0,004  Antineoplastic (squamous cell carcinoma)
0,688  0,003  Alpha tubulin antagonist
0,687  0,007  Antineoplastic (melanoma)
0,685  0,007  NOS2 expression inhibitor
0,673  0,008  Antineoplastic (cervical cancer)
0,660  0,005  Antineoplastic (multiple myeloma)
0,655  0,010  5 Hydroxytryptamine release stimulant
0,650  0,005  CYP2C19 inhibitor
0,635  0,007  Antineoplastic (brain cancer)
0,632  0,004  Hepatoprotectant
0,640  0,019  Antileukemic
0,619  0,007  Antineoplastic (glioma)
0,610  0,005  Antineoplastic (glioblastoma multiforme)
0,614  0,010  Hepatic disorders treatment
0,615  0,014  Antineoplastic (ovarian cancer)
0,587  0,003  Beta tubulin antagonist
0,591  0,012  Antineoplastic (pancreatic cancer)
0,572  0,015  Chemopreventive
0,581  0,031  CYP3A4 substrate
0,550  0,006  Antineoplastic (renal cancer)
0,549  0,006  P-glycoprotein inhibitor
0,576  0,034  Transcription factor NF kappa B inhibitor
0,530  0,013  Antipyretic
0,514  0,010  Antineoplastic (lymphoma)
0,511  0,022  Spasmolytic
0,516  0,033  CYP2C9 substrate
0,498  0,019  Lipoxygenase inhibitor
0,469  0,004  Neurotrophic factor enhancer
0,480  0,016  DNA damaging
0,480  0,022  Antioxidant
0,458  0,012  Antineoplastic (lymphocytic leukemia)
0,495  0,056  Antineoplastic (solid tumors)
0,444  0,006  Liver fibrosis treatment
0,454  0,022  Vasodilator, coronary
0,437  0,009  Topoisomerase II inhibitor
0,448  0,019  Cardiodepressant
0,440  0,014  RNA-directed DNA polymerase inhibitor
0,435  0,014  Antineoplastic (small cell lung cancer)
0,433  0,023  Hypoxia-inducible factor 1 alpha inhibitor
0,454  0,048  Histamine release inhibitor
0,428  0,029  Cytostatic
0,419  0,026  Free radical scavenger
0,423  0,034  12-Lipoxygenase inhibitor
0,403  0,014  Muscle relaxant
0,448  0,062  TNF expression inhibitor
0,443  0,057  15-Lipoxygenase inhibitor
0,405  0,022  Vasodilator
0,397  0,026  Nitric oxide antagonist
0,387  0,018  Abortion inducer
0,373  0,012  Skeletal muscle relaxant
0,392  0,034  Sensitization
0,384  0,026  Antineoplastic (liver cancer)
0,380  0,025  Sigma receptor agonist
0,399  0,055  Vasodilator, peripheral
0,365  0,022  Cyclic AMP phosphodiesterase inhibitor
0,372  0,037  CYP1A2 inhibitor
0,341  0,010  Acetylcholinesterase inhibitor
0,337  0,008  Topoisomerase I inhibitor
0,374  0,048  AR expression inhibitor
0,368  0,043  CYP3A4 inhibitor
0,337  0,014  Lipid peroxidase inhibitor
0,327  0,019  Melanin inhibitor
0,350  0,044  UGT2B4 substrate
0,344  0,041  Proliferative diseases treatment
0,316  0,021  Antiseptic
0,355  0,060  ICAM1 expression inhibitor
0,323  0,033  Antihypertriglyceridemic
0,307  0,016  Genotoxic
0,306  0,017  Amylase inhibitor
0,342  0,055  Calcium channel activator
0,307  0,024  VCAM1 expression inhibitor
0,316  0,035  Antineoplastic (sarcoma)
0,320  0,041  Amyloid beta aggregation inhibitor
0,308  0,031  Anesthetic general
0,325  0,053  Antineoplastic (osteosarcoma)
0,324  0,060  CYP2D6 inhibitor
0,284  0,021  Cholinergic
0,275  0,014  Heat shock protein 90 antagonist
0,285  0,027  Pneumotoxic
0,262  0,006  Microtubule formation inhibitor
0,297  0,045  DNA synthesis inhibitor
0,262  0,018  NADPH oxidase inhibitor
0,246  0,005  Antineoplastic alkaloid
0,317  0,079  Bone diseases treatment
0,314  0,076  Apoptosis antagonist
0,366  0,129  Alpha-glucosidase inhibitor
0,253  0,020  LDLR expression enhancer
0,282  0,048  Psychostimulant
0,253  0,019  Antineoplastic (bone cancer)
0,276  0,044  Antiparkinsonian, rigidity relieving
0,271  0,038  Antiviral (Influenza)
0,297  0,068  CYP2C19 substrate
0,238  0,008  Dopamine D1 antagonist
0,244  0,015  UGT2B10 substrate
0,297  0,078  Respiratory analeptic
0,230  0,012  Topoisomerase II alpha inhibitor
0,270  0,057  Cytotoxic
0,281  0,075  Antiosteoporotic
0,272  0,072  UGT1A9 substrate
0,267  0,067  Tumour necrosis factor alpha release inhibitor
0,289  0,089  Sodium/bile acid cotransporter inhibitor
0,222  0,025  Carcinogenic, group 1
0,307  0,110  CYP2C9 inhibitor
0,222  0,026  CDC-like kinase 1 inhibitor
0,275  0,081  CYP1A2 substrate
0,213  0,019  Butyrylcholinesterase inhibitor
0,304  0,112  Immunosuppressant
0,226  0,037  Antineoplastic (gastric cancer)
0,204  0,017  Alpha 2 adrenoreceptor antagonist
0,211  0,025  Antiviral (Hepatitis B)
0,193  0,008  CDC-like kinase 3 inhibitor
0,187  0,004  Heat shock protein 90 beta antagonist
0,230  0,046  Male reproductive disfunction treatment
0,294  0,111  Ulceration
0,200  0,018  Alpha 2c adrenoreceptor antagonist
0,230  0,052  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,197  0,020  Cyclooxygenase 3 inhibitor
0,201  0,024  Alpha 2b adrenoreceptor antagonist
0,201  0,031  Antifungal enhancer
0,204  0,034  ATPase inhibitor
0,276  0,107  Cholesterol antagonist
0,250  0,083  Transcription factor STAT3 inhibitor
0,209  0,044  Heat shock protein 90 alpha antagonist
0,206  0,041  Antiviral (Influenza A)
0,180  0,015  Multidrug resistance-associated protein 1 inhibitor
0,238  0,079  Cardiovascular analeptic
0,296  0,138  Antibacterial
0,238  0,081  Tyrosine 3 hydroxylase inhibitor
0,199  0,043  Contraceptive
0,241  0,087  Antineoplastic (bladder cancer)
0,177  0,023  Choleretic
0,217  0,064  Sedative
0,166  0,014  DOPA decarboxylase inhibitor
0,226  0,076  Antihypotensive
0,214  0,065  Carcinogenic
0,189  0,044  Erectile dysfunction treatment
0,192  0,050  Antiviral (Herpes)
0,175  0,034  DNA intercalator
0,161  0,020  Breast cancer-resistant protein inhibitor
0,226  0,087  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,172  0,034  Antitussive
0,153  0,015  Inducible nitric-oxide synthase inhibitor
0,150  0,013  CDC25A inhibitor
0,166  0,029  Expectorant
0,238  0,104  Cardioprotectant
0,246  0,113  CTGF expression inhibitor
0,182  0,051  Arachidonic acid antagonist
0,154  0,025  Antiviral (Influenza B)
0,205  0,078  Pyruvate kinase inhibitor
0,131  0,004  Endothelin receptor antagonist
0,238  0,112  Analeptic
0,205  0,081  Antineoplastic enhancer
0,142  0,019  UGT2B11 substrate
0,138  0,018  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,126  0,006  Topoisomerase II beta inhibitor
0,132  0,013  ATPase (Vacuolar H+) inhibitor
0,193  0,075  Platelet adhesion inhibitor
0,161  0,045  Adenylate cyclase stimulant
0,138  0,022  Histidine decarboxylase inhibitor
0,130  0,016  Phosphodiesterase XI inhibitor
0,130  0,016  Phosphodiesterase 11A inhibitor
0,140  0,028  Estrogen antagonist
0,156  0,044  Alkylator
0,190  0,079  Non-steroidal antiinflammatory agent
0,180  0,070  UGT2B7 substrate
0,188  0,078  CYP2B6 inhibitor
0,248  0,141  Antiprotozoal (Plasmodium)
0,124  0,017  Phosphodiesterase V inhibitor
0,174  0,068  Phobic disorders treatment
0,165  0,060  UGT2B15 substrate
0,218  0,114  Chemoprotective
0,143  0,041  Antineoplastic (uterine cancer)
0,201  0,100  Antiprotozoal (Leishmania)
0,166  0,066  Uterine stimulant
0,141  0,043  Papain-like protease (SARS coronavirus) inhibitor
0,112  0,015  Postmenopausal disorders treatment
0,182  0,086  UGT1A1 substrate
0,124  0,028  Estrogen receptor beta antagonist
0,097  0,004  Endothelin B receptor antagonist
0,104  0,013  Antitreponemal
0,095  0,004  Endothelin A receptor antagonist
0,117  0,027  Restless leg syndrome treatment
0,124  0,036  Anabolic
0,112  0,024  Keratolytic
0,095  0,009  Estrogen receptor alpha agonist
0,109  0,023  Phosphodiesterase 5A inhibitor
0,250  0,164  Antiprotozoal
0,090  0,005  Ryanodine receptor antagonist
0,123  0,038  Antineoplastic antibiotic
0,156  0,071  Interferon gamma antagonist
0,129  0,046  Antifungal (Pneumocystis)
0,224  0,142  GST M1-1 substrate
0,163  0,080  Mutagenic
0,146  0,064  Anesthetic
0,108  0,029  Contraceptive male
0,204  0,126  5 Hydroxytryptamine 1E antagonist
0,139  0,062  Skin whitener
0,225  0,148  Antithrombotic
0,103  0,026  Dopamine agonist
0,184  0,109  Antiviral (HIV)
0,136  0,061  Antihemorrhagic
0,153  0,080  UGT1A3 substrate
0,150  0,077  UGT2B9 substrate
0,142  0,069  Pregnane X receptor agonist
0,110  0,038  SULT1E1 substrate
0,173  0,102  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,090  0,020  Estrogen agonist
0,165  0,098  UDP-glucuronosyltransferase substrate
0,208  0,142  Antifungal
0,157  0,092  Antipruritic, non-allergic
0,092  0,029  HIV-1 integrase (3'-Processing) inhibitor
0,090  0,027  HIV-1 integrase (Strand Transfer) inhibitor
0,094  0,031  Estrogen receptor alpha antagonist
0,123  0,060  Alcohol dehydrogenase substrate
0,140  0,079  Acaricide
0,129  0,069  Vanilloid 1 agonist
0,070  0,011  Factor III inhibitor
0,073  0,016  Dopamine D2 agonist
0,081  0,026  Glutamate (mGluR7) antagonist
0,148  0,093  Interleukin 6 antagonist
0,096  0,044  Antiviral (Hepatitis A)
0,114  0,063  Cystathionine beta-synthase inhibitor
0,105  0,054  Alpha adrenoreceptor antagonist
0,154  0,103  Toxic, respiratory center
0,152  0,102  Catenin beta inhibitor
0,110  0,064  Mucolytic
0,076  0,031  SULT2A1 substrate
0,171  0,126  UGT1A6 substrate
0,163  0,119  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,130  0,086  Antimutagenic
0,160  0,119  Insulin sensitizer
0,127  0,086  Protein kinase stimulant
0,066  0,026  Postcoital contraceptive
0,195  0,156  NOS3 expression inhibitor
0,084  0,045  Dopamine antagonist
0,131  0,094  Acetylcholine M1 receptor antagonist
0,165  0,128  Antiamyloidogenic
0,091  0,055  Calcium antagonist
0,098  0,063  Nitric-oxide synthase inhibitor
0,082  0,047  Alpha 2a adrenoreceptor antagonist
0,071  0,037  Dopamine D3 antagonist
0,056  0,022  Dopamine D5 antagonist
0,188  0,154  CYP2D6 substrate
0,174  0,141  Hypoglycemic
0,118  0,087  Bone formation stimulant
0,072  0,043  Dopamine D2 antagonist
0,112  0,084  Contraceptive female
0,271  0,244  Antiinflammatory
0,099  0,073  Antiprotozoal (Toxoplasma)
0,133  0,107  Heat shock protein 70 antagonist
0,147  0,123  Teratogen
0,098  0,075  UGT2B1 substrate
0,192  0,169  5 Hydroxytryptamine uptake stimulant
0,101  0,079  Interleukin 1b antagonist
0,064  0,042  Transcription factor RelA inhibitor
0,145  0,122  Succinate dehydrogenase inhibitor
0,030  0,009  Dopamine D1 agonist
0,109  0,091  Cyclooxygenase 1 inhibitor
0,078  0,060  Glycine receptor antagonist
0,037  0,019  Tubulin agonist
0,124  0,107  Hemostatic
0,057  0,041  Lipocortins synthesis agonist
0,121  0,107  Antiprotozoal (Coccidial)
0,066  0,052  Elastase 1 inhibitor
0,081  0,068  Vanilloid agonist
0,056  0,044  Aromatase inhibitor
0,147  0,136  Antiparasitic
0,062  0,050  Phosphodiesterase III inhibitor
0,044  0,034  Adenylate cyclase 1 inhibitor
0,075  0,066  Opioid kappa receptor antagonist
0,085  0,076  5-Lipoxygenase inhibitor
0,076  0,067  Carcinogenic, group 2A
0,059  0,052  CDC25B inhibitor
0,095  0,088  SULT1A1 substrate
0,044  0,039  Phosphodiesterase 6C inhibitor
0,019  0,014  Progesterone receptor B antagonist
0,065  0,061  Glutamate decarboxylase inhibitor
0,110  0,106  Antiparkinsonian, tremor relieving
0,125  0,122  Dual specificity phosphatase 3 inhibitor
0,149  0,146  Platelet antagonist
0,102  0,102  Constipation treatment

